Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III chemohormonal therapy versus hormonal therapy alone in advanced prostate cancer
2004-003495-11Phase 3Active
- Sponsor
- AOU Città della Salute e della Scienza di Torino
- Start
- Mar 2007
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of docetaxel in prostate cancer (PCa) (3 arms), sponsored by AOU Città della Salute e della Scienza di Torino. Started Mar 2007; status: active.
02
Drugs
docetaxel
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2004-003495-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003495-11.